DAN A23 (Ranitidine Hydrochloride 300 mg)
Pill with imprint DAN A23 is Yellow, Elliptical / Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Schein.
Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; gerd; duodenal ulcer prophylaxis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DAN A23
Ranitidine Hydrochloride
- Imprint
- DAN A23
- Strength
- 300 mg
- Color
- Yellow
- Shape
- Elliptical / Oval
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Schein
- National Drug Code (NDC)
- 00364-2634
More about ranitidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 152 Reviews
- Drug class: H2 antagonists
- FDA Alerts (18)
Consumer resources
- Ranitidine
- Ranitidine Injection
- Ranitidine Suspension
- Ranitidine Syrup
- Ranitidine Tablets and Capsules
Other brands: Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
